TipRanks
Advertisement
Advertisement
Stramsen Biotech Valued at $19 Billion as It Prepares Capital Markets Push and FDA Milestones
PremiumPrivate CompaniesStramsen Biotech Valued at $19 Billion as It Prepares Capital Markets Push and FDA Milestones
7M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―